Gaudium IVF & Women Health IPO Review 2026: GMP Rises Flat, Key Investor Insights

Gaudium IVF & Women Health IPO is open for bidding from 20th February 2026 to 24th February 2026. It is a bookbuilding IPO of ₹165.00 crore, comprising an entirely fresh issue of 1.14 crore shares and an offer-for-sale of 0.95 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 27th February 2026. 

Gaudium IVF & Women Health IPO Details 

The Gaudium IVF & Women Health IPO date is fixed between 20th February 2026 to 24th February 2026. The face value of Gaudium IVF & Women Health shares stands at ₹10 per share, and the IPO Issue price band is set at ₹75 to ₹79 per share

Bigshare Services Private Limited is the registrar of the Gaudium IVF & Women Health IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Gaudium IVF & Women Health IPO Share Reservation

Riddhi Display Equipment’s IPO is a bookbuilding issue of 1.14 crore shares, worth ₹165.00 crore. Gaudium IVF & Women Health IPO Limited shares will be listed on the BSE and the SME Exchange. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Gaudium IVF & Women Health IPO GMP Grey Market Premium

GMP is the gap between the issue price band and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Gaudium IVF & Women Health IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 20th February 2026, Gaudium IVF & Women Health IPO GMP stands at ₹0.00 per share, which means the share will likely list at ₹79.00 on its tentative listing date, 27th February 2026.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Gaudium IVF & Women Health IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends. 

Gaudium IVF & Women Health IPO GMP Review

Check out the detailed Gaudium IVF & Women Health GMP IPO review for a thorough understanding of its potential to report listing gains on 27th February 2026. The Gaudium IVF & Women Health IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business’s economic growth and decline before applying for the Gaudium IVF & Women Health IPO.

Gaudium IVF & Women Health Limited’s revenue increased by 47.37% from ₹48.15 crores in March 2024 to ₹70.96 crores in March 2025. Moreover, the company’s PAT increased by 85.36% from ₹10.32 crores in March 2024 to ₹19.13 crores in March 2025.

Gaudium IVF & Women Health’s IPO has shown consistent revenue growth, indicating the company’s financial stability. Moreover, brokers, investors, and RAs have a positive outlook for the Gaudium IVF & Women Health IPO, with its tentative listing day set for 27th February 2026. 

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Gaudium IVF & Women Health IPO.

The P/E ratio of Gaudium IVF & Women Health Limited shares is 25.36, and its Earnings Per Share (EPS) stands at 3.12. Thus, the Gaudium IVF & Women Health IPO can deliver gains on its tentative listing date, 27th February 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Gaudium IVF & Women Health Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Gaudium IVF & Women Health IPO Subscription Status

The Gaudium IVF & Women Health IPO will open for bidding on 20th February 2026. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Gaudium IVF & Women Health IPO Subscription Status. 

About Gaudium IVF & Women Health Limited

Gaudium IVF & Women Health Incorporated in March 2015, Gaudium IVF and Women Health Limited have been involved in In Vitro Fertilisation (IVF) procedures across India and have extended their services to several states using a hub-and-spoke model of operation. The firm has more than thirty locations, consisting of seven hubs (centres) and twenty-eight spokes. The firm has formed a strategic alliance with Infertility Experts, referred to as Spokes, to attain the common goal of creating awareness about Assisted Reproductive Technology (ART) and In Vitro Fertilisation (IVF) procedures. The firm provides services to patients belonging to different nations, such as Canada, the United Kingdom, the United States of America, Kenya, South Africa, and Oman.

Gaudium IVF & Women Health Limited Financials

The company’s financial analysis is essential before applying for the Gaudium IVF & Women Health IPO. See the table for Gaudium IVF & Women Health Limited’s financials. 

Explanation

Gaudium IVF & Women Health Limited’s revenue increased by 47.37% from ₹48.15 crores in March 2024 to ₹70.96 crores in March 2025. Moreover, the company’s PAT increased by 85.36% from ₹10.32 crores in March 2024 to ₹19.13 crores in March 2025.

Gaudium IVF & Women Health Limited IPO Promoter Holdings

Have a look at the table below to check the holdings of Ashish Kankaria, Shruti A. Kankaria, Ambica Capital Markets Limited, and Gold View Financial Services Limited.

Note: The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue.

Aim of the Gaudium IVF & Women Health IPO

The primary aim of the Gaudium IVF & Women Health IPO is to raise ₹88.88 crores. On the other hand, Fractal Analytics has decided to utilise these funds in different ways.

• To fund capital expenditure towards the establishment of the New IVF Centres of the Company.
• To General Corporate Purposes
• To Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company.

Should I Invest in the Gaudium IVF & Women Health IPO?

Explore the pros and cons of Gaudium IVF & Women Health to know whether you should apply or avoid the issue. These pros and cons might help you understand the IPO’s efficiency in delivering profits over the coming decades. 

Pros of the Gaudium IVF & Women Health IPO

• The company has established central hubs in prime urban locations, including Mumbai, Bangalore, Delhi NCR, and Patna.
• The company has highly technical USG-guided services.
• The Company’s Asset-Light Business Model

Cons of the Gaudium IVF & Women Health IPO

• The company is heavily dependent on the medical workforce.
• The company faces regulatory and compliance uncertainty.
• The Company’s Operational & Expansion Challenges.

How to Apply for the Gaudium IVF & Women Health IPO?

Check the steps mentioned below to apply for Gaudium IVF & Women Health Ltd.

• Step 1: Conduct thorough research on the Gaudium IVF & Women Health IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account with Univest to access real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for 1 lots of 189 shares worth ₹14,931.
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Gaudium IVF & Women Health IPO across multiple demat accounts to increase your chances of allotment. 

How to Check the Gaudium IVF & Women Health IPO Allotment Status?

You can check for the Gaudium IVF & Women Health IPO allotment in different ways. These include NSE and the registrar portal. Follow the steps below to check your allotment status online.

Check On BSE

• Visit the NSE Official Site
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Gaudium IVF & Women Health IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Gaudium IVF & Women Health IPO allotment status.

Let’s Wrap

Gaudium IVF & Women Health IPO is a bookbuilding issue of shares worth ₹165.00 crores. The shares of Gaudium IVF & Women Health Limited will be listed on BSE and NSE on its tentative listing date of 27th February 2026. Researching the Gaudium IVF & Women Health IPO GMP and reviews is highly recommended to achieve your desired profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Gaudium IVF & Women Health IPO

How is the Gaudium IVF & Women Health IPO?

Ans. Currently, on 20th February 2026, the Gaudium IVF & Women Health GMP (Grey Market Premium) stands at ₹0. It indicates that the estimated listing price could be ₹79.00 per share. It is a bookbuilding IPO of ₹165.00 shares. The face value of each Gaudium IVF & Women Health share is ₹5 per share. 

What is the Gaudium IVF & Women Health IPO price?

Ans. The Gaudium IVF & Women Health IPO issue price band is set at ₹75 to ₹79 per share. 

Is the Gaudium IVF & Women Health IPO a good investment?

Ans. Gaudium IVF & Women Health Limited’s revenue increased by 47.37% from ₹48.15 crores in March 2024 to ₹70.96 crores in March 2025. Moreover, the company’s PAT increased by 85.36% from ₹10.32 crores in March 2024 to ₹19.13 crores in March 2025.

Who is the registrar of the Gaudium IVF & Women Health IPO?

Ans. Bigshare Services Private Limited is the registrar for the Gaudium IVF & Women Health IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Gaudium IVF & Women Health allotment and refund, you can contact Bigshare Services Private Limited at ipo@bigshareonline.com or at +91-22-6263 8200.

What is the issue size of the Gaudium IVF & Women Health IPO? 

Ans. Gaudium IVF & Women Health IPO is a bookbuilding IPO of ₹165.00 crores. Moreover, the IPO is set to open on 20th February 2026 and close on 24th February 2026. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Gaudium IVF & Women Health IPO, download the Gaudium IVF & Women Health IPO RHP and Gaudium IVF & Women Health IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

Marushika Technology IPO Day 2: Subscription at 0.38x, GMP Flat | Live Updates

PAN HR Solutions IPO Listing at 0.44% Premium at ₹78.35 Per Share

Biopol Chemicals IPO Listing at 3.00% Premium at ₹111.00 Per Share

Best 1-Year SIP Plans 2026: Top Monthly SIP Plans in India

Marushika Technology IPO Day 3: Subscription at 2.02x, GMP Flat | Live Updates

Fractal Industries IPO Day 1: Subscription at 0.03x, GMP Flat | Live Updates

Marushika Technology IPO Allotment Status: 2.02x Subscribed, GMP Flat — Check Online